SLAMF6 and neoplasm: Furthermore, anti-SLAMF6/CD352 monoclonal antibodies demonstrated anti-tumor activity against CA46 human lymphoma xenografts in nude mice and against systemically disseminated Raji human lymphoma cells in severe combined immunodeficient mice [61].